These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36969381)

  • 1. Towards reproducible structure-based chemical categories for PFAS to inform and evaluate toxicity and toxicokinetic testing.
    Patlewicz G; Richard AM; Williams AJ; Judson RS; Thomas RS
    Comput Toxicol; 2022 Nov; 24():. PubMed ID: 36969381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Chemical Category-Based Prioritization Approach for Selecting 75 Per- and Polyfluoroalkyl Substances (PFAS) for Tiered Toxicity and Toxicokinetic Testing.
    Patlewicz G; Richard AM; Williams AJ; Grulke CM; Sams R; Lambert J; Noyes PD; DeVito MJ; Hines RN; Strynar M; Guiseppi-Elie A; Thomas RS
    Environ Health Perspect; 2019 Jan; 127(1):14501. PubMed ID: 30632786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Per- and Polyfluoroalkyl substances (PFAS) assessments for high throughput screening: Analytical and testing considerations to inform a PFAS stock quality evaluation framework.
    Smeltz MG; Clifton MS; Henderson WM; McMillan L; Wetmore BA
    Toxicol Appl Pharmacol; 2023 Jan; 459():116355. PubMed ID: 36535553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A New CSRML Structure-Based Fingerprint Method for Profiling and Categorizing Per- and Polyfluoroalkyl Substances (PFAS).
    Richard AM; Lougee R; Adams M; Hidle H; Yang C; Rathman J; Magdziarz T; Bienfait B; Williams AJ; Patlewicz G
    Chem Res Toxicol; 2023 Mar; 36(3):508-534. PubMed ID: 36862450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Evidence Map for Over One Hundred and Fifty Per- and Polyfluoroalkyl Substances (PFAS).
    Carlson LM; Angrish M; Shirke AV; Radke EG; Schulz B; Kraft A; Judson R; Patlewicz G; Blain R; Lin C; Vetter N; Lemeris C; Hartman P; Hubbard H; Arzuaga X; Davis A; Dishaw LV; Druwe IL; Hollinger H; Jones R; Kaiser JP; Lizarraga L; Noyes PD; Taylor M; Shapiro AJ; Williams AJ; Thayer KA
    Environ Health Perspect; 2022 May; 130(5):56001. PubMed ID: 35580034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Per- and Polyfluoroalkyl Substances (PFAS)
    Carstens KE; Freudenrich T; Wallace K; Choo S; Carpenter A; Smeltz M; Clifton MS; Henderson WM; Richard AM; Patlewicz G; Wetmore BA; Paul Friedman K; Shafer T
    Chem Res Toxicol; 2023 Mar; 36(3):402-419. PubMed ID: 36821828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for grouping per- and polyfluoroalkyl substances (PFAS) to protect human and environmental health.
    Cousins IT; DeWitt JC; Glüge J; Goldenman G; Herzke D; Lohmann R; Miller M; Ng CA; Scheringer M; Vierke L; Wang Z
    Environ Sci Process Impacts; 2020 Jul; 22(7):1444-1460. PubMed ID: 32495786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Modeling of Human Serum Albumin Binding of Per- and Polyfluoroalkyl Substances Employing QSAR, Read-Across, and Docking.
    Gallagher A; Kar S; Sepúlveda MS
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Protein Binding Evaluations of Per- and Polyfluoroalkyl Substances for Category-Based Toxicokinetic Assessment.
    Smeltz M; Wambaugh JF; Wetmore BA
    Chem Res Toxicol; 2023 Jun; 36(6):870-881. PubMed ID: 37184865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assembly and Curation of Lists of Per- and Polyfluoroalkyl Substances (PFAS) to Support Environmental Science Research.
    Williams AJ; Gaines LGT; Grulke CM; Lowe CN; Sinclair GFB; Samano V; Thillainadarajah I; Meyer B; Patlewicz G; Richard AM
    Front Environ Sci; 2022 Apr; 10():1-13. PubMed ID: 35936994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Throughput Screening of ToxCast PFAS Chemical Library for Potential Inhibitors of the Human Sodium Iodide Symporter.
    Stoker TE; Wang J; Murr AS; Bailey JR; Buckalew AR
    Chem Res Toxicol; 2023 Mar; 36(3):380-389. PubMed ID: 36821091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research.
    Fenton SE; Ducatman A; Boobis A; DeWitt JC; Lau C; Ng C; Smith JS; Roberts SM
    Environ Toxicol Chem; 2021 Mar; 40(3):606-630. PubMed ID: 33017053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring Potential Carcinogenic Activity of Per- and Polyfluorinated Alkyl Substances Utilizing High-Throughput Toxicity Screening Data.
    Singh N; Hsieh CYJ
    Int J Toxicol; 2021; 40(4):355-366. PubMed ID: 33944624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the applicability of the threshold of toxicological concern for per- and polyfluoroalkyl substances.
    Lea IA; Pham LL; Antonijevic T; Thompson C; Borghoff SJ
    Regul Toxicol Pharmacol; 2022 Aug; 133():105190. PubMed ID: 35662637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Category-Based Toxicokinetic Evaluations of Data-Poor Per- and Polyfluoroalkyl Substances (PFAS) using Gas Chromatography Coupled with Mass Spectrometry.
    Kreutz A; Clifton MS; Henderson WM; Smeltz MG; Phillips M; Wambaugh JF; Wetmore BA
    Toxics; 2023 May; 11(5):. PubMed ID: 37235277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid assessment bioaccumulation screening (RABS) study design for emerging per-and polyfluoroalkyl substances in mice exposed to industrially impacted surface water.
    Bangma J; Guillette TC; Strynar M; Lindstrom A; McCord J; Hill D; Lau C; Chernoff N; Lang JR
    Chemosphere; 2022 Dec; 308(Pt 1):136159. PubMed ID: 36064024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactivity profiling of per- and polyfluoroalkyl substances (PFAS) identifies potential toxicity pathways related to molecular structure.
    Houck KA; Patlewicz G; Richard AM; Williams AJ; Shobair MA; Smeltz M; Clifton MS; Wetmore B; Medvedev A; Makarov S
    Toxicology; 2021 Jun; 457():152789. PubMed ID: 33887376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating Molecular Mechanisms of Immunotoxicity and the Utility of ToxCast for Immunotoxicity Screening of Chemicals Added to Food.
    Naidenko OV; Andrews DQ; Temkin AM; Stoiber T; Uche UI; Evans S; Perrone-Gray S
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33804855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations for toxicity experiments and risk assessments with PFAS mixtures.
    McCarthy CJ; Roark SA; Middleton ET
    Integr Environ Assess Manag; 2021 Jul; 17(4):697-704. PubMed ID: 33749053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology Evidence for Health Effects of 150 per- and Polyfluoroalkyl Substances: A Systematic Evidence Map.
    Radke EG; Wright JM; Christensen K; Lin CJ; Goldstone AE; Lemeris C; Thayer KA
    Environ Health Perspect; 2022 Sep; 130(9):96003. PubMed ID: 36178797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.